ICPE conference
Michael D. Murray
-
Register
- Non-Members - Free!
- Members - Free!
An interview with Michael D. Murray, PharmD, MPH, FISPE
Time | Topic |
0:11 | Please provide a brief overview of your career and current position |
| Professor of Pharmacy at Purdue University and Principal at Regenstreif Institute work on longitudinal EHR records since 1979 (with Tom MacDonald) |
1:11 | Please tell us about the early years of ISPE |
| At 2nd meeting- Small, cordial group, very good and fun start to ISPE |
1:54 | How did you first hear about ISPE? |
| Flyer from Hugh Tilson went to head of my Department- interested because of ongoing questions about how to use EMR data. |
2:52 | Did attendees consider themselves pharmacoepidemiologists at the time? |
| Membership survey in 1990-91- many considered themselves PEists even though they were in diverse roles across academia, industry, and regulation. |
4:26 | What do you remember about your first ICPE meeting? |
| Cordial and fun group of people- wanted to know more than just what you did at work. |
5:30 | Did you attend ICPE from then on? |
| Have attended all but a few. |
6:09 | How have you seen ISPE grow and develop over the years? |
| Not very many methodologists at the beginning- many have fused into the group over time and now have a very strong methods group |
7:42 | Were you a part of forming ISPE? |
| Started attending meetings before society formed, was an early board member in the 1990s, when a lot of the strategic planning was happening. |
8:26 | Can you reflect on the creation of by-laws and the early formation of the society? |
| Handful of people that knew how to handle bylaws, and familiar with forming really strong organizational structures |
9:28 | What has been your impact on ISPE? |
| Chair of the membership committee in the 1990s- doing membership surveys and learning about diversity of cultures within membership, as a result. |
11:07 | How has being part of ISPE impacted you, personally or professionally? |
11:45 | “Rounded me off”- new efficiencies, strong methods, paying attention to the best methodologies. |
12:19 | What do you think is ISPE’s greatest impact on the field? |
| Clinical Epidemiology (and David Sackett’s book) is the basic science for medicine. Pharmacoepidemiology not that far behind. Identification of biases that can creep into studies. |
13:49 | What impact has Regenstreif had on pharmacoepi? |
| Idea that the EMR needed to be more medical. Instead of keeping track of costs and charges, computerization of medicine needs to facilitate the chart. |
15:30 | Not just biomedical informatics, but also health services research group, and geriatrics group. |
16:23 | How have you affected pharmacoepi? |
| Spent a lot of time developing methods to remove the noise and preserve the signal in observational medical data. |
19:37 | What wisdom would you like to pass to future leaders and members of ISPE? |
| Continue developing and refining methods to reduce bias in studies. Gaining valuable insights by getting outside the realm of what you do day-to-day- physics, medicine, clinical pharmacology. |
21:12 | What do you see as the future of ISPE? |
21:51 | Industry, regulatory agency, and academia came together to create a strong strategic plan that still resonates with what we are trying to do today. |
22:16 | Do most people who came to ICPE in the beginning continue to attend? |
| Many core individuals still come, who were influential from the beginning- Michael Lewis, Ulf Bergman, Hugh Tilson, Stan Edlavich, Jerry Avorn, Alec Walker, Elizabeth Andrews |
24:16 | Can you recall any seminal moments for ISPE? |
| Infusion of new individuals that have been trained in organizational work- Mark Epstein- guidance in planning and management. |
With support from Epi Excellence LLC.